The relationship of C-reactive protein levels and clinical implications of myocardial infarction during hospital stay
https://doi.org/10.24884/1682-6655-2014-13-2-37-40
Abstract
The Multifunctional acute phase's protein - C-reactive protein (CRP) is involved in the pathogenesis of atherosclerosis. It's elevated concentrations significantly predict atherothrombotic events and consequences of myocardial infarction (MI). The aim of the work was to determine the relationship of CRP levels and clinical course of MI during in-hospital stay. Article presents data of hospital charts of 309 patients with MI treated in the St. Petersburg Research Institute for emergency medical care from January to May 2012. Patients were divided into 2 groups. The first one (I) includes 66 patients with MI and CRP level less than 5 mg/l, the second group (II) - 243 patients with CRP greater than 5 mg/l. In II group significantly more frequent Q-myocardial infarction occurred as well as postinfarction angina, recurrent myocardial infarction and heart failure. Hospital mortality among these patients was significantly higher.
About the Authors
V. A. Kostenko
Institute for Emergency Medical Care of I.I. Dzhanelidze
Russian Federation
Russian Federation
E. A. Skorodumova
Institute for Emergency Medical Care of I.I. Dzhanelidze
Russian Federation
Russian Federation
A. N. Fedorov
Institute for Emergency Medical Care of I.I. Dzhanelidze
Russian Federation
Russian Federation
O. G. Kiselgof
Institute for Emergency Medical Care of I.I. Dzhanelidze
Russian Federation
Russian Federation
References
1. Беляева О. Д., Березина А. В., Баженова Е. А. и др. Толщина комплекса интима-медиа сонных артерий при снижении массы тела немедикаментозными способами у больных абдоминальным ожирением // Регионарное кровообращение и микроциркуляция. 2012. № 3 (43). С. 28-33.
2. Грацианский Н. А. Острый коронарный синдром без подъемов сегмента ST на ЭКГ: патогенез и оценка риска основных осложнений. URL: http://www.athero.ru/ACS_pathol.htm.
3. Вельков В. В. С-реактивный белок в лабораторной диагностике острых воспалений и в оценке рисков сосудистых патологий // Клинико-лаборатор. консилиум. 2008. № 2 (21). С. 37-48.
4. Гублер Е. В. Вычислительные методы анализа и распознавания патологических процессов. Л., 1978. 296 с.
5. Макконен К. Ф., Суязова С. Б., Осипова О. А. и др. Содержание провоспалительных цитокинов и С-реактивного белка у больных хронической сердечной недостаточностью с систолической и диастолической дисфункцией левого желудочка сердца // Фундамент. исслед. 2012. № 7. С. 123-127.
6. Скворцов А. А., Мареев В. Ю., Беленков Ю. Н. Система натрийуретических пептидов. Патофизиологическое и клиническое значение при хронической сердечной недостаточности // Кардиология. 2003. № 8. С. 83-93.
7. Libby P Current concepts of the pathogenesis of the acute coronary syndromes // Circulation. 2001. Vol. 104. Р. 365-372.
8. Luizzo G., Biasucci L. M., Gallimore J. R. et al. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina // N. Engl. J. Med. 1994. Vol. 331. Р. 417-424.
9. Morrow D. A., Rifai N., Antman E. M. et al. C-reactive protein is a potent predictor of mortality independently of and in combination with troponin t in acute coronary syndromes: a TIMI 11a substudy // J. Am. Coll. Cardiol. 1998. Vol. 31. Р. 1460-1465.
10. Nissen S. E., Tuzcu E. M., Schoenhagen P. et al. Reversal of Atherosclerosis with Aggressive Lipid Lowering (REVERSAL)Investigators // N. Engl. J. Med. 2005. Vol. 352. № 1. Р. 29-38.
11. Pepys M. P., Hirschfield G. M. C-reactive protein and atherothrombosis // Ital. Heart. J. 2001. Vol. 2. № 3. Р. 196-199.
12. Ridker P. M., Cannon C. P., Morrow D. et al. Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI22) Investigators. C-reactive protein levels and outcomes after statin therapy // N. Engl. J. Med. 2005. Vol. 352. № 1. Р. 20-28.
13. Ridker P. M., Morrow D. A., Rose L. M. et al. Relative efficacy of atorvastatin 80 mg and pravastatin 40 mg in achieving the dual goals of low-density lipoprotein cholesterol №70 mg/dl and C-reactive protein №2 mg/l: an analysis of the PROVE-ITTIMI-22 trial // J. Am. Coll. Cardiol. 2005. Vol. 45. № 10. Р. 1644-1648.
14. Sharma S. K., Siddiqui S., Fyfe B. et al. A. Histopathologic comparison of culprit vs. non-culprit lesions in the same patient: multivessel atherectomy tissue analysis in acute coronary syndromes: abstract // JACC1996. Vol. 27. Р. 251A.
15. Van der Wal A. C., Becker A. E., van der Loos C. M., Das P. K. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology // Circulation. 1994. Vol. 89. Р. 36-44.
16. Verma S. C-reactive protein incites atherosclerosis // Can. J. Cardiol. 2004. № 20 (Suppl B). Р. 29B-31B.
Review
For citations:
Kostenko V.A., Skorodumova E.A., Fedorov A.N., Kiselgof O.G. The relationship of C-reactive protein levels and clinical implications of myocardial infarction during hospital stay. Regional blood circulation and microcirculation. 2014;13(2):37-40. (In Russ.) https://doi.org/10.24884/1682-6655-2014-13-2-37-40
Views:
916
Email this article 
